TP0502-B-Pharmaco-Scintigraphic-Study

Clinical trial NCT02306798 · COMPLETED

Trial details

NCT number: NCT02306798
Sponsor: Tillotts Pharma AG
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2013-09-01
Primary completion: 2013-11-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.